This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Whether a woman is covered by Medicare or by commercial insurance appears to influence the type of treatment she will likely undergo for uterine fibroids, researchers have reported. A team led by Pratik Shukla, MD, of Rutgers New Jersey Medical School, Newark, NJ, found that women covered by Medicaid are 38% more likely to undergo uterine artery embolization (UAE) for fibroids than those with commercial insurance -- but that if they undergo hysterectomy or myomectomy they are 20% less likely to
TrueLearn has expanded its digital learning and analytics offerings with the acquisition of Medality (formerly MRI Online), a provider of education and practice development for radiologists. Under the agreement, TrueLearns platform will integrate Medalitys offerings, TrueLearn said. Medalitys case-based microlearning and clinical simulations are developed in partnership with academic radiologists and are designed to help enable radiologists to upskill efficiently in high-growth imaging areas, im
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
The specialty has seen a notable rise in applications among aspiring radiology residents and a corresponding uptick in competitiveness, experts write in Academic Radiology.
The specialty has seen a notable rise in applications among aspiring radiology residents and a corresponding uptick in competitiveness, experts write in Academic Radiology.
Understanding the disparities in diagnostic breast imaging can facilitate the development of interventions that aim to close gaps," says Marissa B. Lawson, MD.
These findings raise the question of whether insurance reimbursement impacts referral patterns for other conditions and specialties, and the extent to which it may outweigh evidence-based care decisions.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has approved Puerto Rico for its 13th chapter. The new chapter's official name is theSociety of Nuclear Medicine and Molecular Imaging of Puerto Rico. It is the first new SNMMI chapter since 1986, and its mission is to advance research, education, and the dissemination of new technologies and modalities in the field of nuclear medicine.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Hepatic resection is one of the curative treatments for liver lesions, but patients with chronic liver disease or cirrhosis are at increased risk of post-hepatectomy liver failure (PHLF). So, effective preoperative assessment of liver function is crucial to mitigate this risk. Shear wave elastography (SWE), a non-invasive imaging technique, has shown potential in assessing liver stiffness.
Scottsdale, AZ-based outpatient medical imaging provider SimonMed Imaging will deploy HeartLung Technologies AI software for osteoporosis screening on CT scans. Under the agreement, SimonMed will integrate the software as an add-on to CT scans. The software, AutoBMD AI, opportunistically detects osteoporosis on CT scans acquired for other reasons so that the patient receives no extra x-ray radiation or scanning time, the companies noted.
Neuroblastoma (NB) is a rare pediatric cancer that primarily arises in the adrenal glands and sympathetic nervous system. Previous research from our group demonstrated that photothermal therapy (PTT) using laser-activated Prussian blue nanoparticles (PBNPs) significantly increased tumor-free survival in a neuroblastoma mouse model. Ultrasound-guided PTT (US-PTT) further improved the efficacy of PBNP-PTT.
West Palm Beach, FL-based private equity firm Grovecourt Capital Partners has acquired intraoperative MRI technology developer IMRIS Imaging. Terms were not disclosed. Founded in Chaska, MN, in 2005, IMRIS designs, manufactures, and services proprietary intraoperative MRI suites used by hospitals and cancer centers worldwide. IMRIS developed a movable MRI that operates on a ceiling-mounted rail system so that it can glide between a diagnostic room and operating room, Grovecourt noted.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Metastatic colorectal cancer (mCRC) treatment remains challenging, with a 5-year survival rate of about 14%. Liver-directed therapy such as Yttrium-90 (Y90) radioembolization may improve progression-free survival (PFS) and overall survival (OS) for patients who progress on systemic therapy. Radiosensitizers, such as capecitabine, may enhance the effects of radioembolization, although data are limited.
Clarity Pharmaceuticals has secured fast-track designation from the U.S. Food and Drug Administration (FDA) for its copper-67 (Cu-67) SAR-bisPSMA radiopharmaceutical for treating advanced prostate cancer. The classification builds on Clarity's earlier receipt of fast-track designation for its PET diagnostic imaging agent Cu-64 SAR-bisPSMA for identifying patients with the disease.
Patients with extreme splenomegaly suffer from compressive symptoms and cytopenia with limited treatment options. Splenectomy in patients with extreme splenomegaly carries a mortality rate of up to 20%. Partial splenic bland embolization can be done but requires multiple embolizations to achieve sufficient splenic size reduction without major morbidity.
Women with uterine fibroids and Medicaid coverage are significantly more likely to be treated with uterine artery embolization than those with commercial insurance, according to newly published research.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Image-guided interventional radiology (IR) treatments like transarterial therapies and percutaneous ablations cause tumor cell lysis and release of intracellular antigens to prime anti-tumor immune responses that can synergize with systemic therapies. Immune response quantification after IR treatments has focused on cellular (T cell) immunity, but knowledge of humoral (B cell) immunity in this context is lacking.
Communicating Effectively with Confidence Confident communication is a vital skill in the workplace and beyond. Whether you're leading a team, completing a project, or navigating difficult conversations, your ability to express ideas clearly, listen actively and provide constructive feedback is crucial for your success. The following is a guest blog post from Cassling Leadership Institute speaker and Executive Coach Nicole Winkler.
Liver transplantation is the gold standard for hepatocellular carcinoma (HCC) therapy. Most undergo bridging locoregional therapy (LRT) until transplantation with post-transplant outcomes correlated with degree of complete pathologic necrosis (CPN). Ablative modalities are available for small tumors, but the optimal modality remains unclear for lesions between 3 to 5 cm in size where it is more difficult to achieve adequate margins given the size of the tumor with thermal ablation.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
Lung shunt fraction (LSF) and lung mean dose (LMD) estimates are key aspects of patient selection and treatment planning in 90Y radioembolization. MAA-based planar imaging yields biased and uncertain LSF and LMD estimates, restricting eligible patients and/or therapy. Prior work has outlined 90Y workflows and clinical studies without planar imaging-based LSF.
For those facilities who still have an active Hologic InSight FD Mini C-Arm in service, take note: Hologic has officially announced end-of-life for the device,
Portal vein embolization (PVE) induces hypertrophy of the future liver remnant (FLR) prior to interval partial hepatectomy. A variety of PVE techniques and outcomes have been reported with varying outcomes. Foaming 3% sodium tetradecyl sulfate (STS) and ethiodized oil with balloon occlusion of the proximal right portal vein allows for isolated embolization of the distal right portal branches.
The PET radiopharmaceutical SAR-bisPSMA has garnered three FDA fast track designations in a six-month period for use in the detection and management of prostate cancer.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
174 
Let's personalize your content